Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah's flagship solution, Genio, uses hypoglossal nerve stimulation, an alternative to CPAP therapy. With Genio, Nyxoah offers a comfortable and elegant treatment alternative that allows patients suffering from obstructive sleep apnea to enjoy life to the fullest.
Major Shareholders
Percentages based on (a) the number of shares held at the time of the transaction that triggered the most recent Belgian transparency notification or US SEC filing, and (b) the current denominator.